Spec sheet · Metabolic & GLP
AOD-9604: specs, mechanism and price check
Modified C-terminal fragment of human growth hormone studied for effects on fat metabolism. AOD-9604 was developed from the lipolytic region of growth hormone.

Specifications
- Y1
- L2
- R3
- I4
- V5
- Q6
- C7
- R8
- S9
- V10
- E11
- G12
- S13
- C14
- G15
- F16
Tyrosine followed by hGH residues 177–191, with one disulfide bond between the two cysteines.
| Property | Value | Source |
|---|---|---|
| CAS number | 221231-10-3 | PubChem CID 71300630 |
| Molecular formula | C78H123N23O23S2 | PubChem CID 71300630 |
| Molecular weight | 1815.1 g/mol | PubChem CID 71300630 |
| PubChem CID | 71300630 | PubChem CID 71300630 |
| Length | 16 residues | PubChem CID 71300630 |
Verified 2026-11-09 against PubChem CID 71300630. Values we couldn't verify are left out.
Price check: #1 vs #2
| #1 Purgo Labs | #2 Panda Peptides | |
|---|---|---|
| Listed item | AOD-9604 5mg | AOD-9604 5mg |
| List price | $49.99 | $26.39 |
| With code | $37.49 (25% off) | No code |
| Proof Score | 100/100 | 94/100 |
| Testing labs named | ILS Laboratories, Freedom Diagnostics +3 | Janoshik Analytical, ILS Laboratories |
| Link | Get 25% off by using code usapeptidevendors | Panda Peptides ↗ |
Receptor pharmacology
Evidence level: Preclinical: mouse studies. All mechanism maps
- Heffernan M et al. The effects of human GH and its lipolytic fragment (AOD9604) on lipid metabolism following chronic treatment in obese mice and beta(3)-AR knock-out mice. Endocrinology. 2001;142:5182-9.
- Heffernan MA et al. Increase of fat oxidation and weight loss in obese mice caused by chronic treatment with human growth hormone or a modified C-terminal fragment. Int J Obes Relat Metab Disord. 2001;25:1442-9.
Research background
AOD-9604 was developed from the lipolytic region of growth hormone. Mouse studies reported increased fat oxidation and weight loss in obese animals.
36 of 112 directory vendors list AOD-9604; 17 name their testing lab.
COA checklist
- Match the CAS number on the certificate to 221231-10-3.
- A 16-residue peptide should show a mass-spec identity near 1815.1 g/mol; HPLC purity alone doesn't confirm identity.
- 36 of the 112 vendors in our directory list AOD-9604; 17 of those name the lab that tests it.
AOD-9604 questions
What is AOD-9604?
Modified C-terminal fragment of human growth hormone studied for effects on fat metabolism. AOD-9604 was developed from the lipolytic region of growth hormone. Mouse studies reported increased fat oxidation and weight loss in obese animals.
What are AOD-9604's CAS number and molecular weight?
CAS 221231-10-3, formula C78H123N23O23S2, 1815.1 g/mol, per PubChem CID 71300630.
Where can US labs buy AOD-9604?
Purgo Labs stocks it as “AOD-9604”; code usapeptidevendors takes 25% off at checkout. This page also lists the best-documented second vendor from our 112-vendor directory.
Is research-grade AOD-9604 for human use?
No. Vendor material is sold for Research Use Only, not for human or veterinary use.